The inhibition of renal sodium-glucose cotransporter 2 (SGLT2) has been proposed as a novel therapeutic approach to diabetic treatment.Here, the effect of d
Metabolic syndrome (MetS) is a complex of metabolic abnormalities such as obesity, hyperglycemia, hyperlipidemia and elevated blood pressure.The results of